Primary |
Atrial Fibrillation |
52.5% |
Arrhythmia |
13.1% |
Heart Rate Irregular |
4.9% |
Product Used For Unknown Indication |
4.9% |
Suicide Attempt |
4.9% |
Hypertension |
3.3% |
Blood Cholesterol Increased |
1.6% |
Bundle Branch Block |
1.6% |
Cardiac Arrest |
1.6% |
Drug Use For Unknown Indication |
1.6% |
Gastrointestinal Stromal Tumour |
1.6% |
Hypercholesterolaemia |
1.6% |
Nodal Arrhythmia |
1.6% |
Percutaneous Coronary Intervention |
1.6% |
Tachycardia |
1.6% |
Tachycardia Foetal |
1.6% |
|
Heart Rate Increased |
11.5% |
Neuropathy Peripheral |
7.7% |
Suicide Attempt |
7.7% |
Thyroid Cancer |
7.7% |
Toxicity To Various Agents |
7.7% |
Blood Pressure Systolic Increased |
3.8% |
Bradycardia |
3.8% |
Cardioactive Drug Level Above Therapeutic |
3.8% |
Deafness Unilateral |
3.8% |
Death |
3.8% |
Headache |
3.8% |
Heart Valve Incompetence |
3.8% |
Hypotension |
3.8% |
Interstitial Lung Disease |
3.8% |
Maternal Drugs Affecting Foetus |
3.8% |
Memory Impairment |
3.8% |
Nausea |
3.8% |
Papilloedema |
3.8% |
Parosmia |
3.8% |
Pneumonia |
3.8% |
|
Secondary |
Atrial Fibrillation |
30.7% |
Hypertrophic Cardiomyopathy |
11.8% |
Product Used For Unknown Indication |
8.7% |
Cerebrovascular Accident Prophylaxis |
7.1% |
Hypertension |
7.1% |
Non-obstructive Cardiomyopathy |
4.7% |
Gastrointestinal Stromal Tumour |
3.9% |
Ventricular Tachycardia |
3.9% |
Arrhythmia |
3.1% |
Gastritis |
3.1% |
Angina Pectoris |
2.4% |
Arrhythmia Prophylaxis |
1.6% |
Arrhythmia Supraventricular |
1.6% |
Atrial Tachycardia |
1.6% |
Cardiac Disorder |
1.6% |
Diabetes Mellitus |
1.6% |
Drug Use For Unknown Indication |
1.6% |
Pollakiuria |
1.6% |
Prophylaxis |
1.6% |
Atrial Flutter |
0.8% |
|
Sudden Death |
11.4% |
Syncope |
11.4% |
White Blood Cell Count Decreased |
11.4% |
Death |
9.1% |
Sick Sinus Syndrome |
9.1% |
Interstitial Lung Disease |
4.5% |
Macroglossia |
4.5% |
Nervousness |
4.5% |
Patent Ductus Arteriosus |
4.5% |
Rash |
4.5% |
Ventricular Tachycardia |
4.5% |
Cardiac Arrest |
2.3% |
Congenital Hypothyroidism |
2.3% |
Drug Interaction |
2.3% |
Embolic Cerebral Infarction |
2.3% |
Face Oedema |
2.3% |
Heart Valve Incompetence |
2.3% |
Medication Error |
2.3% |
Product Quality Issue |
2.3% |
Product Substitution Issue |
2.3% |
|
Concomitant |
Atrial Fibrillation |
18.5% |
Hypertension |
12.1% |
Drug Use For Unknown Indication |
10.1% |
Prophylaxis |
7.3% |
Depression |
5.6% |
Product Used For Unknown Indication |
5.4% |
Rheumatoid Arthritis |
4.8% |
Diabetes Mellitus |
4.2% |
Chronic Obstructive Pulmonary Disease |
4.0% |
Myelodysplastic Syndrome |
3.9% |
Arrhythmia |
3.7% |
Osteoporosis |
3.0% |
Pain |
3.0% |
Cardiac Disorder |
2.8% |
Constipation |
2.7% |
Hormone Replacement Therapy |
2.2% |
Hyperlipidaemia |
1.7% |
Thrombosis Prophylaxis |
1.7% |
Cerebrovascular Accident Prophylaxis |
1.6% |
Parkinson's Disease |
1.5% |
|
Ventricular Septal Defect |
11.2% |
Atrial Fibrillation |
9.0% |
Vomiting |
6.7% |
Nausea |
6.0% |
Tachycardia |
6.0% |
Urinary Retention |
5.2% |
Arrhythmia |
4.5% |
Cerebral Infarction |
4.5% |
Interstitial Lung Disease |
4.5% |
Pyrexia |
4.5% |
Syncope |
4.5% |
Deep Vein Thrombosis |
3.7% |
Oedema Peripheral |
3.7% |
Pain In Extremity |
3.7% |
Renal Failure Acute |
3.7% |
Thrombocytopenia |
3.7% |
Transient Ischaemic Attack |
3.7% |
Ventricular Failure |
3.7% |
Vision Blurred |
3.7% |
Visual Impairment |
3.7% |
|
Interacting |
Angina Pectoris |
17.1% |
Gastritis |
12.9% |
Hypertension |
12.9% |
Arrhythmia |
11.4% |
Anxiety Disorder |
8.6% |
Hyperlipidaemia |
5.7% |
Rheumatoid Arthritis |
5.7% |
Hypertonic Bladder |
4.3% |
Myocardial Infarction |
4.3% |
Atrial Tachycardia |
2.9% |
Blood Pressure |
2.9% |
Constipation |
2.9% |
Arthritis |
1.4% |
Atrial Fibrillation |
1.4% |
Blood Cholesterol Increased |
1.4% |
Depression |
1.4% |
Oral Candidiasis |
1.4% |
Peptic Ulcer |
1.4% |
|
Palpitations |
37.5% |
Blood Pressure Fluctuation |
12.5% |
Condition Aggravated |
12.5% |
Drug Interaction |
12.5% |
Electrocardiogram Qt Prolonged |
12.5% |
Torsade De Pointes |
12.5% |
|